1. GPCR/G Protein
  2. LPL Receptor
  3. TC-SP 14

TC-SP 14 (compound 14) 是一种口服有效的 S1P1 激动剂 (EC50 = 0.042 μM),在 S1P3 处活性极低 (EC50 = 3.47 μM)。TC-SP 14 可显著降低血液淋巴细胞计数,减弱对抗原挑战的迟发型超敏反应(DTH)。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

TC-SP 14 Chemical Structure

TC-SP 14 Chemical Structure

CAS No. : 1257093-40-5

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

TC-SP 14 (compound 14) is an orally active and potent S1P1 agonist (EC50 = 0.042 μM) with minimal activity at S1P3 (EC50 = 3.47 μM). TC-SP 14 significantly reduces blood lymphocyte counts and attenuates a delayed type hypersensitivity (DTH) response to antigen challenge[1].

IC50 & Target

S1PR1

0.042 μM (EC50)

S1PR3

3.47 μM (EC50)

体外研究
(In Vitro)

TC-SP 14 (compound 14) neither inhibits nor induces human cytochrome P450 enzymes, is nonmutagenic, and dose not significantly inhibit the hERG channel[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

TC-SP 14 (compound 14) (0-3 mg/kg, Orally, once) produces a dose-dependent reduction in circulating blood lymphocytes 24 h postdose[1].
TC-SP 14 (0-3 mg/kg, Orally, daily for 10 days) significant reduces ovalbumin (OVA)-induced ear swelling[1].
TC-SP 14 (2-15 mg/kg, IV or PO, once) possesses acceptable characteristics[1].
Pharmacokinetic Parameters of TC-SP 14 in female Sprague-Dawley rats and male Cynomolgus [1].

species rat NHP
CL (L/h/kg) 0.33 0.50
Vss (L/kg) 3.3 1.6
T1/2 (h) 7.5 35.2
MRT (h) 10 3.3
% F 68 23

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Lewis rats (female, n = 5/group)[1]
Dosage: 0.3, 1.0, and 3.0 mg/kg
Administration: Orally, once
Result: Produced a dose-dependent reduction in circulating blood lymphocytes 24 h postdose, resulted in near maximal lymphopenia at 3.0 mg/kg (74% reduction in lymphocytes vs vehicle).
Animal Model: OVA-immunized Lewis rats (female, n = 8/group)[1]
Dosage: 0.1, 0.3, 1.0, and 3.0 mg/kg
Administration: Orally, daily for 10 days
Result: Significant reduced OVA-induced ear swelling at doses of 0.3 mg/kg and higher.
Animal Model: Female Sprague-Dawley rats, Male Cynomolgus (NHP (nonhuman primates)) (n=3/group)[1]
Dosage: 2 (IV, rat), 4 (IV, NHP), 10 (PO, NHP), 15 mg/kg (PO, rat)
Administration: IV, PO, once (Pharmacokinetic Analysis)
Result: Possessed acceptable characteristics, demonstrated low clearance, moderate steady state volumes of distribution, moderate-to-long mean residence times, and acceptable oral bioavailability.
分子量

450.50

Formula

C25H20F2N2O2S

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献

TC-SP 14 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
TC-SP 14
目录号:
HY-108492
需求量: